LY2874455 25 mg | Purity Not Available
TargetMol
LY2874455 has been used in trials studying the treatment of Advanced Cancer.
More Information Supplier PageLY2874455
Search Results
Camostat mesylate 25 mg | 99.69%
TargetMol
Camostat is a trypsin-like protease inhibitor and inhibits airway epithelial sodium channel (ENaC) function.
More Information Supplier PageCamostat mesylate
INH1 100 mg | Purity Not Available
TargetMol
INH1 is a cell-permeable Hec1 inhibitor that specifically disrupts the Hec1/Nek2 interaction.
More Information Supplier PageINH1
IC261 100 mg | 99.86%
TargetMol
IC261 is a novel inhibitor of CK1, triggers the mitotic checkpoint control. The IC50 of IC261 for CK1 was 16 μM and for Cdk5 is 4.5 mM.
More Information Supplier PageIC261
IC261 25 mg | 99.86%
TargetMol
IC261 is a novel inhibitor of CK1, triggers the mitotic checkpoint control. The IC50 of IC261 for CK1 was 16 μM and for Cdk5 is 4.5 mM.
More Information Supplier PageIC261
GSK2801 100 mg | 99.88%
TargetMol
GSK2801 is an effective, specific and cell active acetyl-lysine competitive inhibitor of BAZ2A(Kd: 136 nM) and BAZ2B(Kd: 257 nM) bromodomains.
More Information Supplier PageGSK2801
GSK2801 25 mg | 99.88%
TargetMol
GSK2801 is an effective, specific and cell active acetyl-lysine competitive inhibitor of BAZ2A(Kd: 136 nM) and BAZ2B(Kd: 257 nM) bromodomains.
More Information Supplier PageGSK2801
Camostat mesylate 200 mg | 99.69%
TargetMol
Camostat is a trypsin-like protease inhibitor and inhibits airway epithelial sodium channel (ENaC) function.
More Information Supplier PageCamostat mesylate
Camostat mesylate 100 mg | 99.69%
TargetMol
Camostat is a trypsin-like protease inhibitor and inhibits airway epithelial sodium channel (ENaC) function.
More Information Supplier PageCamostat mesylate
TH287 100 mg | 97.73%
TargetMol
TH287 is a potent inhibitor of MTH1 (NUDT1), less potent for MTH2, NUDT5, NUDT12, NUDT14, and NUDT16.
More Information Supplier PageTH287
